TRAPPC9

Across TCGA pan-cancer cohorts, TRAPPC9 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated TRAPPC9 data layer compared with 20 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher TRAPPC9 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated TRAPPC9 expression acts as an unfavorable survival marker.

LUAD, HNSC, and CCRCC are the cancer types where TRAPPC9 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.891	1.000	.014	5	view →
HNSC	DFS	Median	II,III,IV	0.911	0.977	.031	4	view →
CCRCC	DFS	Median	III,IV	0.567	0.837	.010	4	view →
UCEC	DFS	Median	All	0.935	1.000	.019	2	view →
PDAC	DFS	Quartile	II,III,IV	0.384	0.652	.037	2	view →
LSCC	OS	Median	II,III,IV	0.630	0.856	.039	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

TRAPPC9–LUAD (DFS)

Open the LUAD breakdown →